I disagree. If the patent was never filed the compound is hard to reverse engineer. Even then it has to go to drug trials.

As I stated before most of the research is done by researchers. And drug companies mostly spend on advertising and lobbying and executive pay compared to the money spent on research.

The root of this issue is just having patents for those drugs and not allowing generic drug makes manufacture drugs that are a lot more affordable.

That’s nice. Pretty sure it won’t come to us.